Symptoms and Syndromes 13 Cholestasis

Total Page:16

File Type:pdf, Size:1020Kb

Symptoms and Syndromes 13 Cholestasis Symptoms and Syndromes 13 Cholestasis Page: 1 Definition 228 2 Pathogenesis 228 2.1 Obstructive cholestasis 228 2.2 Non-obstructive cholestasis 229 3 Morphological changes 229 4 Forms of cholestasis 230 5 Causes of cholestasis 230 5.1 Extrahepatic obstructive cholestasis 230 5.2 Intrahepatic obstructive cholestasis 230 5.3 Intrahepatic cholestasis 230 5.4 Genetically determined cholestasis 232 5.4.1 Primary storage diseases 232 5.4.2 Recurrent intrahepatic cholestasis in pregnancy 232 5.4.3 Benign recurrent intrahepatic cholestasis (BRIC) 233 Ϫ Aagenaes syndrome 5.4.4 Progressive familial cholestasis (PFIC) 233 Ϫ Byler’s disease/syndrome 5.4.5 Zellweger’s syndrome 234 5.4.6 Infantile Refsum’s syndrome 234 6 Diagnosis 235 6.1 Anamnesis 235 6.2 Clinical findings 235 6.2.1 Fatigue 235 6.2.2 Pruritus and scratch marks 235 6.2.3 Xanthelasmas and xanthomas 235 6.2.4 Changes in biotransformation 236 6.3 Laboratory diagnostics 236 6.4 Imaging procedures 237 6.4.1 Sonography 237 6.4.2 CT and MRI 238 6.4.3 ERC, PTC and EUS 238 6.5 Liver biopsy and laparoscopy 238 7 Clinical sequelae 240 7.1 Abdominal complaints 240 7.2 Steatorrhoea and diarrhoea 240 7.3 Malabsorption 240 7.4 Osteopathy 240 7.5 Renal dysfunction 240 8 Therapy 240 8.1 Mechanical cholestasis 240 8.2 Functional cholestasis 241 ț References (1Ϫ80) 241 (Figures. 13.1Ϫ13.8; tables 13.1Ϫ13.11) 227 13 Cholestasis 1 Definition 2 Pathogenesis Cholestasis is defined as a disorder of cholepoiesis The liver cell is a polar unit. • The resorptive processes and bile secretion as well as a mechanical or func- take place at the sinusoidal and lateral membrane, the tional stoppage of the bile flow in intrahepatic or secretory processes on the surface of the canaliculi. The extrahepatic bile ducts Ϫ with bile components pass- cytoskeleton (microfilaments, microtubules, intracellu- ing into the blood. • Cholestasis can occur both with lar membranes) maintains the polar orientation of the and without jaundice. hepatocyte. (24, 33, 42, 44, 71, 80) (s. fig. 13.1) Morphology: The morphologist uses the term cholestasis BM CM to describe the presence of bile in the hepatocytes as well + as in hypertrophic Kupffer cells (ϭ cellular bilirubino- 3Na Na+/K+ TJ 2 K+ } ATPase stasis), particularly in the form of inspissated bile droplets Na+ BSEP BS } NTCP BST BS ϭ BS- and copper within the more or less dilated canaliculi ( Phospholipids - MDR2 (= flippase) canalicular bilirubinostasis). • In extrahepatic cholestasis, OA MRP 1 - - AE2 CI HCO3 bile is additionally found within the likewise mostly di- BS- + OA-/OC+ } OATP1 MDR1 OC lated interlobular bile ducts (ϭ ductular bilirubinostasis) GSH - BS HCO3 MRP2 - as well as in the parenchyma in the form of “bile infarcts” (=MOAT) OA ,GSH - Epoxide TJ or “bile lakes”. BS hydrolase Pathophysiology: The biochemist defines cholestasis as BM CM a decrease in the secretion of bile as well as a reduction in the proportion of water, together with a respective Fig. 13.1: The hepatocyte as a polar unit. • Major hepatocellular effect on the substances dissolved in it. transport systems: CM ϭ canalicular membrane, BM ϭ basolateral membrane, TJ ϭ tight junctions, BSϪ ϭ bile salts, OAϪ ϭ organic Clinical aspects: ϩ The clinician diagnoses cholestasis by anions, OC ϭ organic cations, GSH ϭ reduced glutathione, AE2 ϭ Ϫ ϭ the increase in bile acids, special enzymatic markers and ATP-dependent anion exchange (Cl/HCO3 ; GSH), BST ATP- dependent bile acid transporter, NTCP ϭ sinusoidal Naϩ-depend- cholesterol in the serum. ϩ ent taurocholate cotransporting protein, OATP1 ϭ sinusoidal Na - ᭤ The principal biochemical symptom of cholestasis is independent organic anion (and cation) transporter protein, ϭ ϭ the rise in bile acids in serum (as well as changes in its BSEP bile salt export pump for monovalent bile salts, MRP2 canalicular multispecific organic anion transporter (ϭ MOAT), spectrum) in combination with an increase in enzymatic MDR ϭ ATP-dependent organic cation transporter, MDR ϭ γ Ј 1 2 markers of cholestasis (AP, LAP, -GT, 5 -nucleo- ATP-dependent phospholipid transporter (ϭ flippase), MRP1 ϭ tidase). Cholestasis is directly related to the metabolism sinusoidal multidrug resistance-associated protein of bile acids. • In clinical terms, the subsequent rise in activity of enzymatic markers of cholestasis may be attributed to cholestasis, yet these enzymes are not 2.1 Obstructive cholestasis necessarily specific to this condition. (s. p. 89) Obstructive cholestasis Ϫ initially often without jaun- ᭤ Dysfunction in the metabolism of bile acids (ϭ chole- dice, thereafter generally with jaundice Ϫ is caused by a stasis) is often combined with an additional dysfunction mechanical impediment of the bile flow. Because of this, in bilirubin metabolism (ϭ jaundice). The rise in biliru- the bile flow is reduced and biliary stasis is generated, bin is the main biochemical and clinical symptom of which, depending on the localization of the impediment, jaundice; it is based on a disorder of bilirubin metab- subsequently affects the bile ducts of (1.) the entire liver olism. Thus cholestasis is related not directly but in- or (2.) only certain subzones of the liver. directly to jaundice. • Depending on the constellation of Even in cases of a total obstruction with jaundice, there is no total the biochemical and clinical findings, the term “jaundice stoppage of bile secretion due to the residual function of the hepa- with cholestasis” or “cholestasis with jaundice” can be tocytes. What happens, in fact, is that a certain form of circulation applied. (s. tabs. 12.1, 12.2, 12.4; 13.1) • The main clin- of intrahepatic bile acids is maintained by way of resorption pro- ical sign of advanced cholestasis is pruritus. cesses taking place in the bile capillaries and mechanisms of regur- gitation occurring at the tight junctions. This circulation of bile acids mainly runs via the periportal sections of the hepatic lobules, Various hepatobiliary diseases remain unchanged as so that biliary thrombi are only rarely detectable here Ϫ even in either cholestasis or jaundice. • Often, however, a com- cases of prolonged cholestasis. • In obstructive cholestasis, with bination of both disorders is present from the very be- its secondary repercussions on bile capillaries and hepatic cells, ginning or appears during the course of disease. including morphological changes, it is probable that functional dis- orders in the polarity of the hepatocytes will ultimately appear. 228 Cholestasis 2.2 Non-obstructive cholestasis Endotoxins generated in the body are broken down in the RES. Given inadequate clearance (e.g. in chole- Pathogenetically, non-obstructive cholestasis is a multi- stasis) or when they are formed to excess, the state of factorial process. • The factors that cause intrahepatic cholestasis is reinforced. Endotoxins also lead to inflam- cholestasis lead to biochemical dysfunctions and/or matory reactions in the liver and are possibly the cause damage to subcellular structures, with changes in the of complications in cases of prolonged cholestasis. (51) metabolism of bile acids. (1.) Various substances (taurolithocholate, ethinyl oestradiol, The mechanisms of disorder leading to cholestasis drugs, toxins) cause increased retention of cholesterol in cellular are based on many different aetiopathological membranes. As a result, the permeability of hepatocellular mem- factors. One single cause of cholestasis generally dis- branes, including the tight junctions, is decreased. Hypothermia turbs several subprocesses in the metabolism of bile and hypoxia also disturb membrane fluidity. The osmotic pressure acids, which in turn may trigger additional chole- gradient, necessary for biliary secretion, is no longer maintained because of decreased membrane permeability. static mechanisms. Such disorders result in damage to cellular and biliary structures, leading to further (2.) Considerable dysfunction of membrane lipids is caused by a change in the double-bonding of their unsaturated fatty acids due dysfunctions and reinforcing cholestasis. Thus patho- to lipid peroxidation. More pronounced lipid peroxidations are genic mechanisms, acting in a synergy of addition or found particularly in alcohol-induced liver damage Ϫ often ac- potentiation, set up a vicious circle culminating in a companied by cholestasis. cholestatic condition. (15, 18, 22, 33, 44, 71, 80) (3.) Naϩ/Kϩ-ATPase localized in the sinusoidal and lateral hepa- tocyte membrane is inhibited by cholestasis factors (chlorpro- mazine, oestrogens, atypical bile acids, protoporphyrin, etc.) as well as by a change in the viscosity and fluidity of the membrane. Naϩ/Kϩ-ATPase activity works like a metabolic pump and sup- plies the energy needed for the cellular uptake of bile acids (along 3 Morphological changes with bicarbonate and chloride). In the development of morphological damage to hepa- (4.) Mg2ϩ-ATPase activity can likewise be inhibited in the cana- licular side of the membrane by cholestatic factors (in particular tocytes and bile capillaries, lipid peroxidations as well as bile acids). This metabolic pump transports bicarbonate and chlor- the formation of leukotrienes (C4, D4, E4) play a key ide into the canaliculi and is probably closely associated with the role, with prostaglandin E2 having a reinforcing effect. function of the microfilaments. ᭤ After only a few days, cholestasis causes potentially (5.) Transmembranous transport of biliary acids requires the func- ultrastructural changes: tional competence of the carrier proteins in
Recommended publications
  • Case Report Acute Pancreatitis Secondary to Hemobilia After Percutaneous Liver Biopsy: a Rare Complication of a Common Procedure, Presenting in an Atypical Fashion
    Hindawi Case Reports in Gastrointestinal Medicine Volume 2018, Article ID 1284610, 4 pages https://doi.org/10.1155/2018/1284610 Case Report Acute Pancreatitis Secondary to Hemobilia after Percutaneous Liver Biopsy: A Rare Complication of a Common Procedure, Presenting in an Atypical Fashion Ramy Mansour and Justin Miller Genesys Regional Medical Center Gastroenterology, 1 Genesys Parkway, ATTN: Medical Education, Grand Blanc, MI 48439, USA Correspondence should be addressed to Ramy Mansour; [email protected] Received 4 June 2018; Accepted 16 August 2018; Published 2 September 2018 Academic Editor: Engin Altintas Copyright © 2018 Ramy Mansour and Justin Miller. Tis is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Percutaneous Liver Biopsy is an ofen-required procedure for the evaluation of multiple liver diseases. Te complications are rare but well reported. Here we present a case of a 60-year-old overweight female who underwent liver biopsy for elevated alkaline phosphatase. She developed acute pancreatitis secondary to hemobilia, with atypical signs and symptoms, following the biopsy. She never had the classic triad of RUQ pain, jaundice, and upper GI hemorrhage. Tere were also multiple negative imaging studies, thus complicating the presentation. She was successfully treated with ERCP, sphincterotomy, balloon sweep, and stent placement. Angiography and transcatheter embolization were not required. 1. Introduction complained of hematuria during the review of systems. A CT scan was performed without contrast for the hematuria and Histological assessment of the liver is the gold standard for revealed difuse hepatic steatosis.
    [Show full text]
  • Abdominal Distension
    2003 OSCE Handbook The world according to Kelly, Marshall, Shaw and Tripp Our OSCE group, like many, laboured away through 5th year preparing for the OSCE exam. The main thing we learnt was that our time was better spent practising our history taking and examination on each other, rather than with our noses in books. We therefore hope that by sharing the notes we compiled you will have more time for practice, as well as sparing you the trauma of feeling like you‟ve got to know everything about everything on the list. You don‟t! You can‟t swot for an OSCE in a library! This version is the same as the 2002 OSCE Handbook, except for the addition of the 2002 OSCE stations. We have used the following books where we needed reference material: th Oxford Handbook of Clinical Medicine, 4 Edition, R A Hope, J M Longmore, S K McManus and C A Wood-Allum, Oxford University Press, 1998 Oxford Handbook of Clinical Specialties, 5th Edition, J A B Collier, J M Longmore, T Duncan Brown, Oxford University Press, 1999 N J Talley and S O‟Connor, Clinical Examination – a Systematic Guide to Physical Diagnosis, Third Edition, MacLennan & Petty Pty Ltd, 1998 J. Murtagh, General Practice, McGraw-Hill, 1994 These are good books – buy them! Warning: This document is intended to help you cram for your OSEC. It is not intended as a clinical reference, and should not be used for making real life decisions. We‟ve done our best to be accurate, but don‟t accept any responsibility for exam failure as a result of bloopers….
    [Show full text]
  • A Rare Case of Fulminant Hemobilia Resulting from Gallstone Erosion of the Right Hepatic Artery
    CASE REPORT A Rare Case of Fulminant Hemobilia Resulting From Gallstone Erosion of the Right Hepatic Artery Shir Li JEE, MRCS (Edin)*; Kin Foong LIM, FRCS (IRE)**; KRISHNAN Raman, FRCS (Edin)*** *Surgical Trainee, General Surgery, Hospital Selayang, Lebuhraya Selayang-Kepong, Batu Caves, Selangor 68100, Malaysia, **Consultant Hepatobiliary Surgeon, Hepatobiliary Department, Hospital Selayang, ***Senior Consultant Hepatobiliary Surgeon, Hepatobiliary Department, Hospital Selayang µmol/L with predominant direct hyperbilirubinaemia and SUMMARY serum alkaline phosphotase of 208 U/L. The renal profile Hemobilia is a rare but potentially lethal condition. The and tumour markers were normal. commonest cause of hemobilia is trauma, accounting up to 85% of all cases. Hemobilia caused by gallstones is very An oesophago-gastro-duodenoscopy (OGDS) was performed rare. Most of the cases of hemobilia are either managed but failed to identify any active bleeding lesion. A side conservatively or treated by embolization. Surgery is viewing duodenoscopy subsequently revealed intermittent indicated only when there is an associated surgical blood and pus oozing from the papilla of Vater. Endoscopic condition or when embolization fails. We report a case of a retrograde cholangiopancreatography (ERCP) and common 72-year-old patient with massive hemobilia caused by bile duct stenting were carried out. The cholangiogram did gallstone erosion to the adjacent artery, diagnosed intra- not show any filling defect. In view of the finding of operatively. The complication was successfully managed by haemobilia, an abdominal computerised tomography cholecystectomy and repair of the bleeding vessel. This angiography (CTA) was done. The CTA did not reveal any case highlights the importance that hemobilia should be active contrast extravasation and all visualized vessels were suspected in patients presenting with upper gastrointestinal normal in caliber.
    [Show full text]
  • Transjugular Intrahepatic Portosystemic Shunt (TIPS); Review of Initial Experience at Aga Khan University Hospital Rana Shoaib Hamid Aga Khan University
    eCommons@AKU Department of Radiology Medical College, Pakistan April 2011 Transjugular intrahepatic portosystemic shunt (TIPS); review of initial experience at Aga Khan University Hospital Rana Shoaib Hamid Aga Khan University Tanveer-ul-haq Aga Khan University Muhammad Azeemuddin Aga Khan University Zafar Sajjad Aga Khan University Ishtiaq Chishti Aga Khan University See next page for additional authors Follow this and additional works at: http://ecommons.aku.edu/pakistan_fhs_mc_radiol Part of the Radiology Commons Recommended Citation Hamid, R., Tanveer-ul-haq, ., Azeemuddin, M., Sajjad, Z., Chishti, I., Salam, B. (2011). Transjugular intrahepatic portosystemic shunt (TIPS); review of initial experience at Aga Khan University Hospital. Journal of the Pakistan Medical Association, 61(4), 336-9. Available at: http://ecommons.aku.edu/pakistan_fhs_mc_radiol/25 Authors Rana Shoaib Hamid, Tanveer-ul-haq, Muhammad Azeemuddin, Zafar Sajjad, Ishtiaq Chishti, and Basit Salam This article is available at eCommons@AKU: http://ecommons.aku.edu/pakistan_fhs_mc_radiol/25 Original Article Transjugular Intrahepatic Portosystemic Shunt (TIPS); review of initial experience at Aga Khan University Hospital Rana Shoaib Hamid, Tanveer-ul-Haq, Muhammad Azeemuddin, Zafar Sajjad, Ishtiaq Chishti, Basit Salam Radiology Department, Aga Khan University Hospital, Karachi, Pakistan. Abstract Objective: To retrospectively assess the therapeutic effectiveness and safety of transjugular intrahepatic portosystemic shunt (TIPS) in patients with portal hypertension related complications. Methods: Over a period of 7.5 years 19 patients (10 males and 9 females, age range 25-69 years) were referred for TIPS at our radiology department. Thirteen patients suffered from liver cirrhosis while 6 had Budd Chiari syndrome. All patients were evaluated with colour doppler ultrasonography and cross sectional imaging.
    [Show full text]
  • Upper Gastrointestinal Bleeding: a Rare Complication of Acute Cholecystitis
    CASE REPORT – OPEN ACCESS International Journal of Surgery Case Reports 4 (2013) 761–764 View metadata, citation and similar papers at core.ac.uk brought to you by CORE Contents lists available at SciVerse ScienceDirect provided by Elsevier - Publisher Connector International Journal of Surgery Case Reports journa l homepage: www.elsevier.com/locate/ijscr Upper gastrointestinal bleeding: A rare complication of acute cholecystitis a,∗ b b a Gael R. Nana , Matthew Gibson , Archie Speirs , James R. Ramus a Department of Surgery, Royal Berkshire Hospital, Reading, Berkshire RG1 5AN, UK b Department of Radiology, Royal Berkshire Hospital, Reading, Berkshire RG1 5AN, UK a r t i c l e i n f o a b s t r a c t Article history: INTRODUCTION: Haemobilia is a rare complication of acute cholecystitis and may present as upper gas- Received 28 May 2013 trointestinal bleeding. Received in revised form 31 May 2013 PRESENTATION OF CASE: We describe two patients with acute cholecystitis presenting with upper gas- Accepted 31 May 2013 trointestinal bleeding due to haemobilia. Bleeding from the duodenal papilla was seen at endoscopy Available online 15 June 2013 in one case but none in the other. CT demonstrated acute cholecystitis with a pseudoaneurysm of the cystic artery in both cases. Definitive control of intracholecystic bleeding was achieved in both cases by Keywords: embolisation of the cystic artery. Both patients remain symptom free. One had subsequent laparoscopic Haemobilia Pseudoaneurysm cholecystostomy and the other no surgery. Cholecystitis DISCUSSION: Pseudoaneurysms of the cystic artery are uncommon in the setting of acute cholecystitis. Transarterial embolisation OGD and CT angiography play a key role in diagnosis.
    [Show full text]
  • Anaemia in Alimentary Tract Disease
    Open Access Austin Journal of Gastroenterology Review Article Anaemia in Alimentary Tract Disease Weledji EP* Department of Surgery, Faculty of Health Sciences, Abstract University of Buea, S.W. Region, Cameroon, W/Africa Blood loss from the alimentary tract may be chronic and occult resulting *Corresponding author: Elroy Patrick Weledji, in anaemia, or, acute requiring emergency resuscitation, investigation and Department of Surgery, Faculty of Health Sciences, management. Anaemia in alimentary tract disease usually results from deficiency University of Buea, S.W. Region, Cameroon, W/Africa of iron, vitamin B12 or folic acid. In this review, the common causes of chronic anaemia manifesting in the alimentary tract are discussed. The importance of Received: April 06, 2019; Accepted: May 03, 2019; clinically diagnosing and treating the underlying disease is emphasized. Published: May 10, 2019 Keywords: Bleeding; Chronic; Anaemia; Disease; Alimentary tract Introduction chronic blood loss is located in the small bowel [1,2-4,7,9]. Anaemia may be the result of blood loss due to a number of Iron-deficiency anaemia causes in the gastrointestinal tract. The loss can be obvious and Although the major cause of iron deficiency anaemia is blood spectacular as in bleeding oesophageal varices, peptic ulcer, or loss from the alimentary tract, in women menstrual blood loss must insidious and occult from a colonic polyp. Anaemia can also be also be considered. In some cases of chronic and occult blood loss the due to malabsorption of iron, folate, and vitamin B12 because of patient may present with symptoms of anaemia, such as, dyspnoea, a variety of disease, or can simply reflect an inadequate dietary dizziness, or angina.
    [Show full text]
  • Acute Cholangitis: Diagnosis and Management
    Journal of Visceral Surgery (2019) 156, 515—525 Available online at ScienceDirect www.sciencedirect.com REVIEW Acute cholangitis: Diagnosis and management a b a,c A. Sokal , A. Sauvanet , B. Fantin , a,c,∗ V. de Lastours a Internal medicine unit, hôpital Beaujon, Assistance—publique des Hôpitaux de Paris, 92110 Clichy, France b Hepatic and pancreatic surgery unit, digestive disease center, hôpital Beaujon, Assistance—publique des Hôpitaux de Paris, 92110 Clichy, France c Inserm, IAME, UMR 1137, université Paris Diderot, 75018 Paris, France Available online 24 June 2019 KEYWORDS Summary Acute cholangitis is an infection of the bile and biliary tract which in most cases is the consequence of biliary tract obstruction. The two main causes are choledocholithiasis Acute cholangitis; Etiology; and neoplasia. Clinical diagnosis relies on Charcot’s triad (pain, fever, jaundice) but the insuf- Epidemiology; ficient sensitivity of the latter led to the introduction in 2007 of a new score validated by the Management Tokyo Guidelines, which includes biological and radiological data. In case of clinical suspicion, abdominal ultrasound quickly explores the biliary tract, but its diagnostic capacities are poor, especially in case of non-gallstone obstruction, as opposed to magnetic resonance cholangiopan- creatography and endoscopic ultrasound, of which the diagnostic capacities are excellent. CT scan is more widely available, with intermediate diagnostic capacities. Bacteriological sampling through blood cultures (positive in 40% of cases) and bile cultures is essential. A wide variety of bacteria are involved, but the main pathogens having been found are Escherichia coli and Klebsiella spp., justifying first-line antimicrobial therapy by a third-generation cephalosporin.
    [Show full text]
  • Mechanisms of Drug-Induced Liver Injury: the Role of Hepatic Transport Proteins
    MECHANISMS OF DRUG-INDUCED LIVER INJURY: THE ROLE OF HEPATIC TRANSPORT PROTEINS Kyunghee Yang A dissertation submitted to the faculty of the University of North Carolina at Chapel Hill in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the Eshelman School of Pharmacy Chapel Hill 2014 Approved by: Kim L.R. Brouwer Paul B. Watkins Dhiren Thakker Harvey J. Clewell III Brett A. Howell ©2014 Kyunghee Yang ALL RIGHTS RESERVED ii ABSTRACT Kyunghee Yang: Mechanisms of Drug-Induced Liver Injury: The Role of Hepatic Transport Proteins (Under the direction of Kim L.R. Brouwer) The objectives of this research were to investigate mechanisms of drug-induced liver injury (DILI) that involve drug-bile acid (BA) interactions at hepatic transporters, and develop a novel strategy to reliably predict human DILI. Troglitazone (TGZ), an antidiabetic withdrawn from the market due to severe DILI, was employed as a model hepatotoxic drug. Pharmacokinetic modeling of taurocholic acid (TCA, a model BA) disposition data from human and rat sandwich-cultured hepatocytes (SCH) revealed that species differences exist in TCA hepatocellular efflux pathways; in human SCH, TCA biliary excretion predominated, whereas biliary and basolateral excretion contributed equally to TCA efflux in rat SCH. This finding explains, in part, why rats are less susceptible to DILI compared to humans after administration of drugs that inhibit BA biliary excretion. The present study also revealed for the first time that TGZ sulfate (TS), a major TGZ metabolite, inhibits BA basolateral efflux in addition to biliary excretion. These findings support the hypothesis that TS is an important mediator of altered hepatic BA disposition; increased hepatic TS exposure due to impaired canalicular transport function might predispose a subset of patients to hepatotoxicity.
    [Show full text]
  • Recurrent Acute Pancreatitis Due to Haemobilia from a Hepatic Artery Aneurysm A
    Postgrad Med J: first published as 10.1136/pgmj.59.695.590 on 1 September 1983. Downloaded from Postgraduate Medical Journal (September 1983) 59, 590-592 Recurrent acute pancreatitis due to haemobilia from a hepatic artery aneurysm A. S. MEE J. A. MCM. TURNER M.D., M.R.C.P. M.R.C.P. N. MENZIES GOW F.R.C.S. Departments of Gastroenterology, Medicine and Surgery, Central Middlesex Hospital, Acton Lane, London NW10 Summary history of malaise, lethargy and anorexia and a 4-day A case of recurrent acute pancreatitis due to haemo- history of vomiting. Following one episode of vomit- bilia secondary to a bleeding hepatic artery aneurysm ing, she had brought up fresh blood clots. Two days is presented. Embolization of the hepatic artery before admission, she complained of a continuous resulted in cessation of bleeding and resolution of aching pain in the right hypochondrium which pancreatitis. persisted for 24 hr. On the was examination, patient well-nourished,by copyright. KEY WORDS: recurrent pancreatitis, haemobilia, hepatic artery pyrexial 38-2°C and jaundiced. The abdomen was aneurysm. soft with no palpable masses. Rectal examination showed no melaena. Introduction Investigations showed haemoglobin 12-3 g/dl, Haemobilia remains an uncommon cause of gas- white cell count 22-4 x 109/litre, erythrocyte sedimen- trointestinal haemorrhage. Trauma accounts for the tation rate 43 mm/hr, bilirubin 110 ,umol/litre, majority of cases although other causes are inflam- alanine aminotransferase 627 iu/litre (normal<35), matory (pyogenic and helminthic), cholelithiasis, aspartate aminotransferase 825 iu/litre (nor- vascular malformations, pancreatitis and neoplasms.
    [Show full text]
  • 4 Liver, Biliary System and Pancreas 4.1 Presenting Problems 4.1.1 Jaundice Ref: Davidson P
    4 Liver, Biliary System and Pancreas 4.1 Presenting Problems 4.1.1 Jaundice Ref: Davidson P. 936, Andre Tan Ch10, JC56, GIL17, Block A TC (jaundice), Uptodate A. Physiology of Bilirubin Excretion Bilirubin: non-toxic breakdown product of heme □ Formed in reticuloendothelial system (RES) □ Two forms: → Unconjugated (indirect) bilirubin: - Not water soluble → bound to plasma protein - Cannot be excreted directly in urine → Conjugated (direct) bilirubin: - Water soluble - Can be excreted directly in urine Hepatic handling: □ Unconjugated bilirubin taken up by hepatocytes □ Bilirubin conjugated by UDP-glucuronyl transferase □ Secreted into bile canaliculi into duodenum Enterohepatic circulation: □ Conjugated bilirubin reduced into urobilinogen by intestinal flora → 10% reabsorbed into portal circulation → secreted in kidney as urobilin → confers straw colour of urine □ Unabsorbed urobilinogen oxidized into stercobilinogen and then stercobilin → confers brown colour of faeces Features of cholestatic jaundice: □ Tea-coloured urine: excretion of conjugated bilirubin in urine (bilirubinuria) □ Pale stools: reduced stercobilin content in stools □ Pruritus: retention of bile acid in blood - Page 171 of 335 - B. Causes of Jaundice Pre-hepatic Hepatic Post-hepatic Suggestive - Lemon yellow jaundice - Yellow jaundice - Greenish jaundice features - Dark stools (↑stercobilin) - Normal stools - Pale stools - Normal urine - Tea-coloured urine - Tea-coloured urine - Pruritus ± scratch marks LFT - ↑unconj. bilirubin - ↑conj. bilirubin - ↑conj. Bilirubin
    [Show full text]
  • University of Groningen Regulation of Hepatic Transport In
    University of Groningen Regulation of hepatic transport in experimental cholestasis Koopen, Nynke Rixt IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document version below. Document Version Publisher's PDF, also known as Version of record Publication date: 1998 Link to publication in University of Groningen/UMCG research database Citation for published version (APA): Koopen, N. R. (1998). Regulation of hepatic transport in experimental cholestasis. [S.n.]. Copyright Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons). The publication may also be distributed here under the terms of Article 25fa of the Dutch Copyright Act, indicated by the “Taverne” license. More information can be found on the University of Groningen website: https://www.rug.nl/library/open-access/self-archiving-pure/taverne- amendment. Take-down policy If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum. Download date: 05-10-2021 Regulation of Hepatic Transport in Experimental Choles Regulation of Hepatic Transport in Experimental Cholestasis Stellingen behorend bij het proefschrift Mechanisms involved in malabsorption of dietary lipids Mini Kalivianakis Groningen, 23 september 1998 Severe fat malabsorption due to impaired lipolysis can be identified by the 13C­ MTG breath test.
    [Show full text]
  • Changes in Glutathione Content in Liver Diseases: an Update
    antioxidants Review Changes in Glutathione Content in Liver Diseases: An Update Mariapia Vairetti , Laura Giuseppina Di Pasqua * , Marta Cagna, Plinio Richelmi, Andrea Ferrigno * and Clarissa Berardo Unit of Cellular and Molecular Pharmacology and Toxicology, Department of Internal Medicine and Therapeutics, University of Pavia, 27100 Pavia, Italy; [email protected] (M.V.); [email protected] (M.C.); [email protected] (P.R.); [email protected] (C.B.) * Correspondence: [email protected] (L.G.D.P.); [email protected] (A.F.); Tel.: +39-0382-98687 (L.G.D.P.); +39-0382-986451 (A.F.) Abstract: Glutathione (GSH), a tripeptide particularly concentrated in the liver, is the most important thiol reducing agent involved in the modulation of redox processes. It has also been demonstrated that GSH cannot be considered only as a mere free radical scavenger but that it takes part in the network governing the choice between survival, necrosis and apoptosis as well as in altering the function of signal transduction and transcription factor molecules. The purpose of the present review is to provide an overview on the molecular biology of the GSH system; therefore, GSH synthesis, metabolism and regulation will be reviewed. The multiple GSH functions will be described, as well as the importance of GSH compartmentalization into distinct subcellular pools and inter-organ transfer. Furthermore, we will highlight the close relationship existing between GSH content and the pathogenesis of liver disease, such as non-alcoholic fatty liver disease (NAFLD), alcoholic liver disease (ALD), chronic cholestatic injury, ischemia/reperfusion damage, hepatitis C virus (HCV), hepatitis B virus (HBV) and hepatocellular carcinoma.
    [Show full text]